IP Verse

Astrazeneca Pharmaceuticals Lp V. Cipla Limited - 3:25-cv-00233

Astrazeneca Pharmaceuticals Lp V. Cipla Limited (Case No. 3:25-cv-00233), filed on Jan 9, 2025 in the District Court, D. New Jersey involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
3:25-cv-00233
Filing Date
Jan 9, 2025
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. New Jersey
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
KUDOS PHARMACEUTICALS LIMITED -
ASTRAZENECA AB -
MSD INTERNATIONAL BUSINESS GMBH -
CIPLA USA, INC. -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jan 9, 2025Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025)PACER Document
Jan 9, 2025Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025)PACER Document
Jan 9, 2025Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025)PACER Document
Jan 9, 2025Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025)PACER Document
Jan 9, 2025Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025)PACER Document
Jan 9, 2025COMPLAINT against CIPLA LIMITED, CIPLA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15928486), Related Case Selected, filed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. (Attachments: # 1 Exhibit A, # 2 Certification (Rule 11.2), # 3 Civil Cover Sheet)(CHEVALIER, CHARLES) (Entered: 01/09/2025)PACER Document
Jan 10, 2025SUMMONS ISSUED as to CIPLA LIMITED, CIPLA USA, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (dmr3) (Entered: 01/10/2025)PACER Document
Jan 10, 2025AO120 Patent Form filed. (dmr3, ) (Entered: 01/10/2025)PACER Document
Jan 22, 2025WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. CIPLA USA, INC. waiver sent on 1/10/2025, answer due 3/11/2025. (CHEVALIER, CHARLES) (Entered: 01/22/2025)PACER Document
Jan 22, 2025WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. CIPLA LIMITED waiver sent on 1/10/2025, answer due 3/11/2025. (CHEVALIER, CHARLES) (Entered: 01/22/2025)PACER Document
Jan 9, 2025Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (dmr3)PACER Document